CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
tipranavirdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00615290
NCT00615290N/ACompleted
CompareCT.gov

Pharmaco-epidemiological Description of the Patient Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

Boehringer Ingelheim·observational·Posted Feb 14, 2008·Updated Aug 8, 2014

In Brief

An observational study evaluating tipranavir for HIV Infections. Completed, enrolled 42 participants across 48 sites.

Detailed Summary

To obtain information on clinical practices for patients treated by Aptivus in real life

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 14, 2008
Enrollment StartJun 1, 2007
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 18.4 years ago

Interventions

tipranavirdrug